重性抑郁障碍反应抑制期认知控制网络连接作为预测与反应生物标志物:一项随机临床试验
该随机临床试验纳入124例重性抑郁障碍门诊患者(随机接受艾司西酞普兰、舍曲林或文拉法辛治疗8周)和59名健康对照,采用Go-NoGo任务及广义心理生理交互分析功能连接。结果显示反应抑制期背外侧前额叶/缘上回与缘上回/颞中回之间的连接选择性且差异化地预测舍曲林和文拉法辛的疗效,并与症状改善相关。
要点
- 反应抑制期认知控制网络连接可差异化预测舍曲林与文拉法辛疗效。
- 舍曲林应答者该连接较高,文拉法辛应答者该连接较低。
- 连接变化与治疗后症状改善相关,支持作为转化生物标志物。
核心结论
- 反应抑制期认知控制环路的连接能选择性且差异化地预测抗抑郁药治疗应答,并与症状改善相关。
研究设计与样本
- 随机临床试验纳入124例重性抑郁障碍门诊患者,随机接受艾司西酞普兰、舍曲林或文拉法辛治疗8周,另纳入59名18-65岁健康对照。
- 治疗前后进行访谈和功能磁共振扫描,采用Go-NoGo任务及广义心理生理交互测量功能连接。
主要发现
- 反应抑制期背外侧前额叶/缘上回与缘上回/颞中回之间的连接与舍曲林和文拉法辛应答相关,但与艾司西酞普兰应答无关。
- 舍曲林应答者上述区域间功能连接高于非应答者,而文拉法辛应答者低于非应答者。
- 舍曲林治疗中中央前回和颞上回连接减弱与治疗后症状改善相关;文拉法辛治疗中眶额皮层与皮层下区域连接增强与症状改善相关。
关键数值与推荐
- 应答定义为自报症状减少≥50%。
- 艾司西酞普兰、舍曲林或文拉法辛治疗8周。
临床怎么用
- 反应抑制期认知控制网络连接有望转化用于预测和评估重性抑郁障碍的抗抑郁药治疗应答。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In treating major depressive disorder, we lack tests anchored in neurobiology that predict antidepressant efficacy. Cognitive impairments are a particularly disabling feature of major depressive disorder. We tested whether functional connectivity during a response-inhibition task can predict response to antidepressants and whether its changes over time are correlated to symptom changes. METHODS: We analyzed data from outpatients with major depressive disorder (n = 124) randomized to receive escitalopram, sertraline, or venlafaxine (8 weeks) and healthy control subjects (n = 59; age 18-65 years). Before and after treatment, participants were interviewed and scanned using functional magnetic resonance imaging, and functional connectivity was measured using generalized psychophysiological interaction during response inhibition (Go-NoGo task). We investigated the interaction between treatment type and response (≥50% reduction on self-reported symptoms), coupling differences between responders and nonresponders at baseline, their correlation with symptom improvement, and their changes in time. RESULTS: During response inhibition, connectivity between the dorsolateral prefrontal cortex/supramarginal gyrus and supramarginal gyrus/middle temporal gyrus was associated with response to sertraline and venlafaxine, but not escitalopram. Sertraline responders had higher functional connectivity between these regions compared with nonresponders, whereas venlafaxine responders had lower functional connectivity. For sertraline, attenuation of connectivity in the precentral and superior temporal gyri correlated with posttreatment symptom improvement. For venlafaxine, enhancement of connectivity between the orbitofrontal cortex and subcortical regions correlated with symptom improvement. CONCLUSIONS: Connectivity of the cognitive control circuit during response inhibition selectively and differentially predicts antidepressant treatment response and correlates with symptom improvement. These quantitative markers tied to the neurobiology of cognitive features of depression could be used translationally to predict and evaluate treatment response.
引用
- Tozzi L, Goldstein-Piekarski AN, Korgaonkar MS, et al. Connectivity of the Cognitive Control Network During Response Inhibition as a Predictive and Response Biomarker in Major Depression: Evidence From a Randomized Clinical Trial. Biol Psychiatry. 2019. PMID: 31601424. doi:10.1016/j.biopsych.2019.08.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。